TrialPain medicine (Malden, Mass.)2023

Preliminary results from a randomized, controlled, cross-over trial of intrathecal oxytocin for neuropathic pain.

James C Eisenach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.